A PYMNTS Company

US: Hart-Scott-Rodino waiting period for AbbVie’s acquisition of Pharmacyclics expires

By  |  May 24, 2015
US: Hart-Scott-Rodino waiting period for AbbVie’s acquisition of Pharmacyclics expires

AbbVie said the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for AbbVie’s purchase of Pharmacyclics expired Friday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The expiration satisfies the exchange offer condition with respect to the approvals and clearances required under antitrust laws.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

     

    Full content: Martket Watch

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.